Are you Dr. Martel?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 33 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
9205 SW Barnes Rd
Portland, OR 97225Phone+1 503-216-7575Fax+1 503-216-7830
Summary
- Dr. Maritza Martel, MD is a board certified pathologist in Portland, Oregon. She is currently licensed to practice medicine in Oregon and Connecticut. She is affiliated with Providence St. Vincent Medical Center, Providence Portland Medical Center, and Providence Milwaukie Hospital.
Education & Training
- Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1999 - 2000
- Yale-New Haven Medical CenterInternship, Transitional Year, 1996 - 1997
- Central University of VenezuelaClass of 1994
Certifications & Licensure
- OR State Medical License 2008 - 2025
- CT State Medical License 2003 - 2010
- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 30 citationsMultiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer.Katherine Sanchez, Isaac Kim, Brie Chun, Joanna Pucilowska, William L. Redmond
Breast Cancer Research. 2021-01-07 - 16 citationsA Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 Therapy.Isaac Kim, Venkatesh Rajamanickam, Brady Bernard, Brie Chun, Yaping Wu
Frontiers in Oncology. 2021-01-01 - 8 citationsMyoepithelial cells in lobular carcinoma in situ: distribution and immunophenotypeYing Wang, Sonali Jindal, Maritza Martel, Yaping Wu, Pepper Schedin
Human Pathology. 2016-09-01
Press Mentions
- Multiplex Immunofluorescence to Measure Dynamic Changes in Tumor-Infiltrating Lymphocytes and PD-L1 in Early-Stage Breast CancerJanuary 7th, 2021